A surveillance system model for central line-associated bloodstream infections (CLABSI) coordinated at the regional level: a pilot feasibility study.

We describe the methods used to define a surveillance model to incorporate into activities aimed at preventing central line-associated bloodstream infections (CLABSI) in non-critical care units (NCCUs) and designed to be implemented at the regional level. In 2015 we conducted a pilot feasibility study in three NCCUs based in hospitals of the Regional Health System of Emilia Romagna to evaluate the feasibility of the proposed model and to test its accuracy and cost-effectiveness in terms of resources needed to maintain the system. Our results indicate that the system is feasible at the regional level by using the available sources and instruments to collect data in clinical practice context. Observation of device utilization for at least three months in all NCCU wards is needed in order to prioritize the medical area on which to focus costs for surveillance prior to implementing it on a regular basis.

[1]  Vital signs: central line-associated blood stream infections--United States, 2001, 2008, and 2009. , 2011, MMWR. Morbidity and mortality weekly report.

[2]  L. Johnston,et al.  The impact of health care restructuring on nosocomial infections and transmission of antimicrobial resistant organisms. , 2001, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses.

[3]  W. Jarvis,et al.  Selected Aspects of the Socioeconomic Impact of Nosocomial Infections: Morbidity, Mortality, Cost, and Prevention , 1996, Infection Control & Hospital Epidemiology.

[4]  Walter Hellinger,et al.  Prevalence of Healthcare-Associated Infections in Acute Care Hospitals in Jacksonville, Florida , 2012, Infection Control & Hospital Epidemiology.

[5]  J. A. Kaan,et al.  Impact of hospital-wide surveillance on hospital-acquired infections in an acute-care hospital in the Netherlands. , 2000, The Journal of hospital infection.

[6]  H. Rüden,et al.  Effectiveness of a nationwide nosocomial infection surveillance system for reducing nosocomial infections. , 2006, The Journal of hospital infection.

[7]  Nosocomial infections: What needs to be done? , 2004, Canadian Medical Association Journal.

[8]  J. Edwards,et al.  National Healthcare Safety Network (NHSN) Report, data summary for 2006, issued June 2007. , 2007, American journal of infection control.

[9]  H Rüden,et al.  Reduction of Surgical Site Infection Rates Associated With Active Surveillance , 2006, Infection Control & Hospital Epidemiology.

[10]  M. Nettleman,et al.  Impact of a dedicated intravenous therapy team on nosocomial bloodstream infection rates. , 1998, American journal of infection control.

[11]  S. Solomon,et al.  Requirements for infrastructure and essential activities of infection control and epidemiology in out-of-hospital settings: a Consensus Panel report. , 1999, American journal of infection control.

[12]  G. Baker,et al.  Adverse events and patient safety in Canadian health care. , 2004, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[13]  Elaine Larson,et al.  A systematic audit of economic evidence linking nosocomial infections and infection control interventions: 1990-2000. , 2002, American journal of infection control.

[14]  A V Swan,et al.  The rate and cost of hospital-acquired infections occurring in patients admitted to selected specialties of a district general hospital in England and the national burden imposed. , 2001, The Journal of hospital infection.

[15]  R. Haley,et al.  The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. , 1985, American journal of epidemiology.

[16]  Dan M. Kluger,et al.  The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. , 2006, Mayo Clinic proceedings.

[17]  J. Burke,et al.  Infection control - a problem for patient safety. , 2003, The New England journal of medicine.

[18]  R. Scott,et al.  The Direct medical costs of healthcare-associated infections in U.S. hospitals and the benefits of prevention , 2009 .

[19]  A. Clark,et al.  Nosocomial infections. An issue of patient safety, Part 2. , 2004, Clinical nurse specialist CNS.

[20]  Daniel J Sexton,et al.  Surgical-Site Infection Due to Staphylococcus aureus Among Elderly Patients Mortality, Duration of Hospitalization, and Cost , 2004, Infection Control & Hospital Epidemiology.

[21]  P. Ragni,et al.  Control of carbapenemase-producing Klebsiella pneumoniae: a region-wide intervention. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[22]  A. Pan,et al.  The Italian national surgical site infection surveillance programme and its positive impact, 2009 to 2011. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[23]  J. Hebden,et al.  Rationale for accuracy and consistency in applying standardized definitions for surveillance of health care-associated infections. , 2012, American journal of infection control.